Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAdc Therapeutics SA Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.22 | -$0.19 | -$0.20 |
| Q2 2026 | 3 | -$0.22 | -$0.19 | -$0.21 |
| Q3 2026 | 3 | -$0.23 | -$0.20 | -$0.22 |
| Q4 2026 | 1 | -$0.22 | -$0.19 | -$0.21 |
| Q1 2027 | 1 | -$0.19 | -$0.17 | -$0.18 |
| Q2 2027 | 1 | -$0.20 | -$0.18 | -$0.19 |
| Q3 2027 | 1 | -$0.16 | -$0.14 | -$0.15 |
| Q4 2027 | 1 | -$0.10 | -$0.08 | -$0.09 |
Adc Therapeutics SA Earnings Date And Information
Adc Therapeutics SA last posted its earnings results on Monday, May 4th, 2026. The company reported $-0.21 earnings per share for the quarter, missing analysts' consensus estimates of $-0.19 by $0.02. The company had revenue of 20.85 M for the quarter and had revenue of 81.36 M for the year. Adc Therapeutics SA has generated $-1 earnings per share over the last year ($-1.12 diluted earnings per share) and currently has a price-to-earnings ratio of -3.92. Adc Therapeutics SA has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Adc Therapeutics SA Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/04/2026 | Q1 2026 | -$0.19 | -$0.21 | -0.02 | $19.99 M | $20.85 M |
| 03/10/2026 | Q4 2025 | -$0.32 | -$0.04 | 0.28 | $22.30 M | $23.06 M |
| 11/10/2025 | Q3 2025 | -$0.40 | -$0.30 | 0.1 | $16.79 M | $16.43 M |
| 08/12/2025 | Q2 2025 | -$0.36 | -$0.50 | -0.14 | $17.86 M | $18.84 M |
| 05/14/2025 | Q1 2025 | -$0.38 | -$0.36 | 0.02 | $17.71 M | $23.03 M |
| 03/27/2025 | Q4 2024 | -$0.35 | -$0.29 | 0.06 | $19.01 M | $16.91 M |
| 11/07/2024 | Q3 2024 | -$0.36 | -$0.42 | -0.06 | $18.43 M | $18.46 M |
| 08/06/2024 | Q2 2024 | -$0.44 | -$0.38 | 0.06 | $18.89 M | $17.41 M |
| 05/06/2024 | Q1 2024 | -$0.56 | -$0.56 | 0 | $18.04 M | $18.05 M |
| 03/13/2024 | Q4 2023 | -$0.47 | -$1.03 | -0.56 | N/A | $16.79 M |
| 11/07/2023 | Q3 2023 | -$0.61 | -$0.58 | 0.03 | N/A | $14.49 M |
| 08/08/2023 | Q2 2023 | -$0.44 | -$0.58 | -0.14 | N/A | $19.28 M |
| 05/09/2023 | Q1 2023 | -$0.80 | -$0.73 | 0.07 | N/A | $18.99 M |
| 03/15/2023 | Q4 2022 | N/A | -$0.30 | N/A | N/A | $69.80 M |
| 11/08/2022 | Q3 2022 | -$0.51 | -$0.65 | -0.14 | N/A | $76.32 M |
| 06/30/2022 | Q2 2022 | N/A | -$0.84 | N/A | N/A | $17.29 M |
| 05/09/2022 | Q1 2022 | -$0.76 | -$0.22 | 0.54 | N/A | $46.50 M |
| 03/17/2022 | Q4 2021 | N/A | -$0.45 | N/A | N/A | $17.01 M |
| 11/02/2021 | Q3 2021 | -$0.97 | -$0.93 | 0.04 | N/A | $13.15 M |
| 06/30/2021 | Q2 2021 | N/A | -$0.95 | N/A | N/A | $3.76 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Adc Therapeutics SA Earnings: FAQ's
The conference call for Adc Therapeutics SA's latest earnings report can be listened to online.
The conference call transcript for Adc Therapeutics SA's latest earnings report can be read online.
Adc Therapeutics SA (:ADCT) has a recorded annual revenue of $81.36 M.
Adc Therapeutics SA (:ADCT) has a recorded net income of $-142,623,000.Adc Therapeutics SA has generated $-1.12 earnings per share over the last four quarters.
Adc Therapeutics SA (:ADCT) has a price-to-earnings ratio of -3.92 and price/earnings-to-growth ratio is -0.13.